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ABSTRACT 
 
An 8-year-old female cockatiel (Nymphicus hollandicus) was presented with anorexia, lethargy, a 
mass beneath the wing and discoloration of the feathers. On physical exam the bird had an 
ulcerative nodular lesion of approximately 4 cm³ ventromedial on the wing. Lateral and 
ventrodorsal radiographs revealed hepatomegaly but no signs of metastasis. After controlling the 
infection (enrofloxacine, 20 mg/kg BW, bid for 7 days), surgical excision of the tumor was 
performed. After histopathological evaluation and bacterial culture, the lesion was typed as an 
integumentary squamous cell carcinoma with bacterial contamination (Corynebacterium sp). Four 
weeks postoperative the tumor had recurred (volume 0.7 cm³). The bird was treated with 
intratumoral carboplatin (1.5 mg/cm³) administration once a week. Because of further tumor 
progression after the second administration of carboplatin, resection of the mass was performed 
before the next infiltration. However, the bird died during anesthesia. Despite increase in tumor 
size, histopathological and immunohistochemical evaluation showed degeneration of the tumor 
with intercellular edema and vacuolization of the tumorcells, presumably resulting from carboplatin 
administration. Intratumoral administration of carboplatin should be considered as a treatment 
option in birds with integumentary squamous cell carcinoma. 
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